22 reports

In order to enhance the long-term market development of the Group and to speed up the pace of the technology innovation, the Group invests tens of millions Yuan each year in research and development in the field of biology, oceanic medication and the technologies such as targeted drug

  • Oncology
  • China
  • Italy
  • Demand
  • Roche Group

In order to enhance the long-term market development of the Group and to speed up the pace of the technology innovation, the Group invests tens of millions Yuan each year in research and development in the field of biology, oceanic medication and the technologies such as targeted drug

  • Oncology
  • China
  • Italy
  • Bayer Schering Pharmaceutical Co., Ltd
  • Roche Group

It is one of the WHO collaborative centers for Cancer Research in China and one of bases for drug clinical Trial of Food and Drug Administration of State (SFDA).

  • Oncology
  • China
  • Italy
  • Novartis AG
  • Sanofi-Synthelabo Inc.

It specializes in development of advanced formulation technology and new drug delivery systems.

  • Oncology
  • China
  • Italy
  • Demand
  • Bayer Schering Pharmaceutical Co., Ltd

In this formulation, paclitaxel is dissolved in Cremophor Chapter IV OVARIAN CANCER TREATMENT DRUGS PRODUCTION AND DEMAND EL and ethanol, as a delivery agent.

  • Oncology
  • China
  • Italy
  • Demand
  • Bayer Schering Pharmaceutical Co., Ltd

In order to enhance the long-term market development of the Group and to speed up the pace of the technology innovation, the Group invests tens of millions Yuan each year in research and development in the field of biology, oceanic medication and the technologies such as targeted drug

  • Oncology
  • China
  • Italy
  • AstraZeneca China Inc.
  • Bayer Schering Pharmaceutical Co., Ltd

It is one of the WHO collaborative centers for Cancer Research in China and one of bases for drug clinical Trial of Food and Drug Administration of State (SFDA).

  • Oncology
  • China
  • Italy
  • Demand
  • Supply

MESALAMINE IS ONE OF THE MOST EXTENSIVELY USED DRUG AMONGST ALL ##-ASA AGENTS.

  • Oncology
  • China
  • Italy
  • Pfizer Inc.
  • Remicade group

Three dose levels of F-## (##, ##, and ## g/ kg) vs. pegfilgrastim were tested in patients receiving the TC regimen, with a randomization ratio of ##:##:##:##.

  • Medical Biotechnology
  • Oncology
  • China
  • Italy
  • GlycoMimetics, Inc.

Enteris' drug delivery solution offers the oral delivery of compounds such as BCS II, III, and IV compounds.

  • Musculoskeletal Disorder
  • Oncology
  • China
  • Italy
  • Amgen Inc.

The Phase II - Trial Details Other Developmental Activities iSPERSE platform enables the delivery of low or high potency drugs to patients across a wide range of inhalation flow rates using existing, simple-to-use, passive dry powder inhalation devices. iSPERSE can enable the

  • Lung Cancer
  • Oncology
  • China
  • Italy
  • Athenex, Inc.
  • GENE THERAPY TO AGONIZE TRAIL RECEPTOR 1 FOR ONCOLOGY - DRUG PROFILE

ABBVIE DISCOVERS AND DEVELOPS NOVEL MEDICINES BASED ON PROTEIN-BASED AND TARGETED DRUG DELIVERY TECHNOLOGIES.

  • Oncology
  • Therapy
  • China
  • Product Initiative
  • AbbVie Inc.

AbbVie discovers and develops novel medicines based on protein-based and targeted drug delivery technologies.

  • Oncology
  • Therapy
  • China
  • Italy
  • AstraZeneca PLC

The successful delivery of this drug is an important step as many others have failed to reach a tumour.

  • Breast Cancer
  • Oncology
  • China
  • Italy
  • AstraZeneca PLC

IT IS DEVELOPED BASED ON COMPUTATIONAL DRUG DELIVERY TECHNOLOGY.

  • Immunotherapy
  • Oncology
  • China
  • Italy
  • TB Drug Development, Inc.

The successful delivery of this drug is an important step as many others have failed to reach a tumor.

  • Breast Cancer
  • Oncology
  • China
  • Italy
  • AstraZeneca PLC
  • AXIAL SPONDYLOARTHRITIS - PIPELINE BY SINO BIOPHARMACEUTICAL LTD, H2 2019

AbbVie discovers and develops novel medicines based on protein-based and targeted drug delivery technologies.

  • Monoclonal Antibody
  • Oncology
  • China
  • Italy
  • Product Initiative

ABBVIE DISCOVERS AND DEVELOPS NOVEL MEDICINES BASED ON PROTEIN-BASED AND TARGETED DRUG DELIVERY TECHNOLOGIES.

  • Immunotherapy
  • Oncology
  • Therapy
  • China
  • Genmab group

THE DRUG CANDIDATE IS BASED ON NANO DRUG DELIVERY SYSTEM.

  • Obesity
  • Oncology
  • China
  • Italy
  • Product Initiative

The company provides RNAi-targeted drugs, delivery systems and DsiRNA molecules.

  • Oncology
  • China
  • Italy
  • Company
  • Product Initiative

The successful delivery of this drug is an important step as many others have failed to reach a tumor.

  • Hospital
  • Oncology
  • China
  • Italy
  • AstraZeneca PLC

It is developed based on liposome drug delivery technology.

  • Oncology
  • Pharmaceutical
  • China
  • Company Operations
  • Fudan-Zhangjiang Bio-Pharmaceutical Co., Ltd.